Total properties:
13
|
|
Patent #:
|
|
Issue Dt:
|
06/05/2001
|
Application #:
|
08913290
|
Filing Dt:
|
03/20/1998
|
Title:
|
METHOD AND COMPOSITION FOR RECONFORMING MULTI-EPITOPIC ANTIGENS TO INITIATE AN IMMUNE RESPONSE
|
|
|
Patent #:
|
|
Issue Dt:
|
04/06/2004
|
Application #:
|
09641833
|
Filing Dt:
|
08/18/2000
|
Title:
|
THERAPEUTIC BINDING AGENTS AGAINST MUC-1 ANTIGEN AND METHODS FOR THEIR USE
|
|
|
Patent #:
|
|
Issue Dt:
|
02/10/2004
|
Application #:
|
09853268
|
Filing Dt:
|
05/11/2001
|
Publication #:
|
|
Pub Dt:
|
11/07/2002
| | | | |
Title:
|
THERAPEUTIC METHOD AND COMPOSITION UTILIZING ANTIGEN-ANTIBODY COMPLEXATION AND PRESENTATION BY DENDRITIC CELLS
|
|
|
Patent #:
|
|
Issue Dt:
|
12/12/2006
|
Application #:
|
09994466
|
Filing Dt:
|
11/26/2001
|
Publication #:
|
|
Pub Dt:
|
09/19/2002
| | | | |
Title:
|
THERAPEUTIC BINDING AGENTS AGAINST MUC-1 ANTIGEN AND METHODS FOR THEIR USE
|
|
|
Patent #:
|
|
Issue Dt:
|
10/18/2011
|
Application #:
|
10831886
|
Filing Dt:
|
04/26/2004
|
Publication #:
|
|
Pub Dt:
|
03/24/2005
| | | | |
Title:
|
COMBINATION THERAPY FOR TREATING DISEASE
|
|
|
Patent #:
|
|
Issue Dt:
|
04/15/2014
|
Application #:
|
13372557
|
Filing Dt:
|
02/14/2012
|
Publication #:
|
|
Pub Dt:
|
01/24/2013
| | | | |
Title:
|
IGE ANTIBODIES FOR THE TREATMENT OF CANCER
|
|
|
Patent #:
|
|
Issue Dt:
|
02/03/2015
|
Application #:
|
13456492
|
Filing Dt:
|
04/26/2012
|
Publication #:
|
|
Pub Dt:
|
03/07/2013
| | | | |
Title:
|
METHODS FOR IMPROVING THE BIOACTIVITY OF THERAPEUTIC IgE ANTIBODIES FOR THE TREATMENT OF DISEASE
|
|
|
Patent #:
|
|
Issue Dt:
|
08/27/2019
|
Application #:
|
15501773
|
Filing Dt:
|
02/03/2017
|
Publication #:
|
|
Pub Dt:
|
08/10/2017
| | | | |
Title:
|
TUMOR ANTIGEN SPECIFIC ANTIBODIES AND TLR3 STIMULATION TO ENHANCE THE PERFORMANCE OF CHECKPOINT INTERFERENCE THERAPY OF CANCER
|
|
|
Patent #:
|
|
Issue Dt:
|
04/13/2021
|
Application #:
|
15541451
|
Filing Dt:
|
07/03/2017
|
Publication #:
|
|
Pub Dt:
|
01/04/2018
| | | | |
Title:
|
METHODS OF INCREASING DELIVERY OF ANTI-CANCER AGENTS TO TARGETS
|
|
|
Patent #:
|
|
Issue Dt:
|
01/21/2020
|
Application #:
|
15654415
|
Filing Dt:
|
07/19/2017
|
Publication #:
|
|
Pub Dt:
|
08/09/2018
| | | | |
Title:
|
TREATMENT OF CANCER WITH THERAPEUTIC MONOCLONAL ANTIBODY SPECIFIC FOR A TUMOR ASSOCIATED ANTIGEN AND AN IMMUNE ADJUVANT
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16448453
|
Filing Dt:
|
06/21/2019
|
Publication #:
|
|
Pub Dt:
|
10/24/2019
| | | | |
Title:
|
TUMOR ANTIGEN SPECIFIC ANTIBODIES AND TLR3 STIMULATION TO ENHANCE THE PERFORMANCE OF CHECKPOINT INTERFERENCE THERAPY OF CANCER
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16482163
|
Filing Dt:
|
07/30/2019
|
Publication #:
|
|
Pub Dt:
|
07/02/2020
| | | | |
Title:
|
METHOD OF INDIRECT IMMUNIZATION OF HUMAN OVARIAN CANCER PATIENTS THROUGH SELECTION OF XENOGENEIC IMMUNOGLOBULIN FC PORTIONS
|
|
|
Patent #:
|
|
Issue Dt:
|
06/07/2022
|
Application #:
|
16702323
|
Filing Dt:
|
12/03/2019
|
Publication #:
|
|
Pub Dt:
|
04/02/2020
| | | | |
Title:
|
TREATMENT OF CANCER WITH THERAPEUTIC MONOCLONAL ANTIBODY SPECIFIC FOR A TUMOR ASSOCIATED ANTIGEN AND AN IMMUNE ADJUVANT
|
|